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The RFX Complex Is Crucial for the Constitutive
and CIITA-Mediated Transactivation
of MHC Class I and b2-Microglobulin Genes
of the NF-kB/Rel family and are thought to be essential
for both constitutive and cytokine-induced expression
(Girdlestone et al., 1993; Mansky et al., 1994). The ISRE
is bound by factors of the interferon regulatory factor
(IRF) family and mediates the induction of MHC class I
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expression by interferons (Girdlestone et al., 1993). Site2333 ZA Leiden
a was originally described as being important for theThe Netherlands
constitutive expression of MHC class I genes (Dey et
al., 1992). However, a crucial role in a novel route of
HLA class I gene activation mediated by the class IISummary
transactivator (CIITA) has recently been attributed to
site a (Gobin et al., 1997; Martin et al., 1997). EnhancerIn type III bare lymphocyte syndrome (BLS) patients,
B contains an inverted CCAAT box sequence that playsdefects in the RFX protein complex result in a lack of
a role in basal MHC class I gene transcription (SchoneichMHC class II and reduced MHC class I cell surface
et al., 1997). In the promoter region of the b2m gene,expression. Using type III BLS cell lines, we demon-
upstream regulatory elements such as GAS/ISRE andstrate that the RFX subunits RFX5 and RFXAP are
kB-like sites are likely to mediate the coordinate cyto-crucial for constitutive and CIITA-induced MHC class
kine-induced expression of b2m and MHC class I genesI and b2m transactivation. Similar to MHC class II, the (GuÈ ssow et al., 1987; IsraeÈ l et al., 1987; Lonergan et al.,promoters of MHC class I and b2m contain an S-X-Y 1993; Drew et al., 1995).
region of which the X1 box is crucial for constitutive The regulation of MHC class II gene transcription is
and CIITA-induced MHC class I and b2m transactiva- mediated principally by four conserved regulatory ele-
tion. Thus, the RFX complex is part of a regulatory ments, the S (also termed W or Z), X1, X2, and Y boxes,
pathway linking the transactivation of MHC class I and which are located in the proximal promoter region (re-
II and their accessory genes. viewed in Ting and Baldwin, 1993; Mach et al., 1996;
Boss, 1997). The regulatory elements in this module are
bound by a number of protein complexes. The X1 box
Introduction is the target binding site for the RFX protein complex,
which consists of at least three subunits, RFX5, RFXAP,
MHC class I and II molecules are membrane-bound gly- and p41 (Mach et al., 1996; Boss, 1997; Moreno et al.,
coproteins that fulfill a key role in the immune response 1997). The adjacent X2 box is bound by X2BP and other
by virtue of their ability to present antigenic peptides to ATF/CREB- and Fos/Jun-related proteins (Moreno et al.,
cytotoxic and helper T lymphocytes, respectively (Ger- 1995). The Y box is bound by the NFY complex (Zeleznik-
main, 1994). MHC class I molecules are expressed at Le et al., 1991; Reith et al., 1994; Wright et al., 1994).
the cell surface associated with b2-microglobulin (b2m), Most of these transcription factors are constitutively
expressed, and the various multiprotein complexes areand both genes are ubiquitously expressed in most adult
thought to be engaged into a single functional regulatorytissues (reviewed in Le Bouteiller, 1994). In contrast,
unit (Reith et al., 1994; Wright et al., 1994; Moreno etthe constitutive expression of MHC class II molecules
al., 1995; Fontes et al., 1997a; Louis-Plence et al., 1997).(consisting of an a and b chain) is restricted to antigen-
However, this regulatory unit is not able to drive MHCpresenting cells, such as dendritic cells and macro-
class II transcription and requires CIITA (Steimle et al.,phages (reviewed in Ting and Baldwin, 1993; Boss,
1993). CIITA acts as a coactivator and is believed to1997). The level of expression of MHC class I and II
exert its activity through these X1 and X2 box bindingmolecules varies considerably among the different tis-
proteins and the basic transcription initiation complexsue types and can be induced by cytokines to meet
(Riley et al., 1995; Zhou and Glimcher, 1995; Fontes etwith local requirements for immune surveillance and an
al., 1997b; Mahanta et al., 1997; Scholl et al., 1997). CIITAefficient immune response. Accordingly, the expression
is constitutively expressed in MHC class II±positive cellsof MHC class I and II molecules is tightly controlled at
such as mature B cells (Silacci et al., 1994). In other cellthe transcriptional level (reviewed in Ting and Baldwin,
types, the expression of CIITA can be induced by IFNg1993; Le Bouteiller, 1994; Mach et al., 1996; Boss, 1997).
(Boehm et al., 1997). In this way, MHC class II expressionThe regulation of MHC class I gene transcription is
is under the control of the IFNg-mediated signal trans-mediated by a number of conserved cis-acting regula-
duction pathway (Boehm et al., 1997, and referencestory elements that include enhancer A, the interferon
therein).
stimulated response element (ISRE), site a, and en-
The importance of CIITA and the RFX complex in the
hancer B (reviewed in Ting and Baldwin, 1993; Le Boute- regulation of MHC class II expression is evident in pa-
iller, 1994). The kB site(s) in the enhancer A element are tients suffering from a congenital immunodeficiency
the target sequences primarily for transcription factors termed bare lymphocyte syndrome (BLS) (reviewed in
Mach et al., 1996; Boss, 1997). BLS patients lack MHC
class II cell surface expression, resulting in impairment* To whom correspondence should be addressed (e-mail: pvdelsen@
of the cellular and humoral immune response. The ge-euronet.nl).
² These authors contributed equally to this work. netic defects of the four BLS complementation groups
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Figure 1. RFX5 or RFXAP Transfection Restores the Reduced Level of MHC Class I and b2m Expression in BLS Type III Cell Lines
(A) The level of MHC class I and class II cell surface expression on mock and RFX5 or RFXAP transfected fibroblast lines of SSI, OSE (both
group C), ABI (group D), and control fibroblasts (WSI) as determined by flow cytometry. MHC class II expression was determined on IFNg-
treated cells (250 U/ml for 48 hr). The weak induction of MHC class II expression by IFNg in ABI fibroblasts is most probably caused by the
low levels of IFNg-induced CIITA, which is specific for this cell line (Peijnenburg et al., 1997). Mean fluorescence values of cells stained for
MHC class I expression were in mock versus RFX5/RFXAP transfected cells: 24.8 versus 42.1 in SSI, 69.4 versus 130.3 in OSE, and 8.1 versus
24.5 in ABI. Control fibroblast cells (WSI) had a mean fluorescence of 126.3. Thin-line histograms represent mock transfected cells; bold line
histograms represent RFX5 or RFXAP transfected cells.
(B) The level of MHC class I, b2m, and MHC class II transcription in mock, RFX5, or RFXAP transfected fibroblast lines of SSI, OSE (both
group C), ABI (group D), and wild-type fibroblasts (DermT), as determined by Northern blot analysis. The cells were either untreated or treated
with IFNg (500 U/ml for 48 hr). The level of GAPDH expression was used as a measure of the relative RNA content in each lane.
characterized so far all reside in genes encoding tran- subunit of RFX (Moreno et al., 1997; Boss, 1997), in
group C in RFX5 (Steimle et al., 1995), and in group Dscription factors that regulate the expression of MHC
class II genes. Apart from group A, which is character- in RFXAP (Durand et al., 1997).
In BLS patients, two phenotypes can be recognized,ized by a defect in CIITA (Steimle et al., 1993), the other
defects reside in genes coding for subunits of the RFX type II and type III, which are both characterized by a
lack of MHC class II expression (Touraine et al., 1985).complex. In group B the defect is presumably in the p41
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However, type III BLS patients display, in addition to MHC class I and b2m gene expression in these type III
BLS patients.the prominent lack of MHC class II expression, a re-
duced level of MHC class I expression (Lambert et al.,
1991; Peijnenburg et al., 1995; Sabatier et al., 1996). This
Subunits of the RFX Complex Regulate Constitutivereduced level of MHC class I cell surface expression is
and CIITA-Mediated MHC Class Imost probably the result of the reduced levels of MHC
and b2m Transactivationclass I heavy chain and b2m transcripts found in cell
The role of RFX5 and RFXAP in MHC class I and b2mlines from type III BLS patients. It has so far remained
transactivation was evaluated further by transient trans-unclear whether this aberrant expression of MHC class I
fection of the BLS fibroblast cell lines with HLA-B7 andand b2m genes could be directly attributed to the genetic
b2m promoter-driven luciferase reporter constructs anddefects in BLS, which involve transcription factors pre-
RFX5 and RFXAP. HLA-DRA-driven reporter constructssumed to be specific for MHC class II expression.
served as positive control. We also included CIITA inIn this study, we demonstrate that this aberrant MHC
these cotransfections, since for MHC class II gene regu-class I expression in type III BLS cells is a direct result
lation, the RFX complex alone is not able to drive trans-of the lack of subunits of the RFX complex, revealing
activation of MHC class II in fibroblasts but also requiresits crucial role in the constitutive and CIITA-mediated
CIITA.transactivation of MHC class I and b2m genes.
In the RFX5-deficient cell lines SSI and OSE (group
C), cotransfection of the MHC class I reporter construct
with RFX5 alone gave rise to an enhanced MHC classResults
I transactivation (Figure 2). Cotransfection of this MHC
class I reporter construct with RFX5 and CIITA resultedStable Transfection of RFX5 and RFXAP Corrects
for the Reduced MHC Class I Expression in a stronger transactivation of the MHC class I promoter
(Figure 2). In contrast, CIITA alone was unable to trans-in BLS Cell Lines
MHC class II deficiency, or BLS, is caused by genetic activate MHC class I in these RFX5-deficient cell lines
(Figure 2). Thus, CIITA appears to be dependent on thedefects in specific transcription factors that are crucial
to and presumed to be specific for the regulation of RFX complex for transactivation of MHC class I. Similar
results were obtained with cotransfection experimentsMHC class II gene expression. However, besides the
lack of MHC class II expression, cells from BLS patients of the b2m reporter construct in the RFX5-deficient cell
lines. RFX5 alone induced transactivation of b2m in thesebelonging to complementation groups C (defective in
RFX5) and D (defective in RFXAP) also display a reduced cell lines (Figure 2). Cotransfection of RFX5 with CIITA
further enhanced b2m transactivation, whereas CIITAlevel of MHC class I expression. This was most pro-
nounced in freshly isolated peripheral blood lymphoid alone did not result in an induction of b2m promoter±
driven transcriptional activity in these RFX5-deficientcells and in in vitro stimulated peripheral T lymphocytes
(data not shown). cell lines (Figure 2). To test whether the enhanced b2m
transactivation by CIITA was specific, similar transfec-To investigate whether this reduction in MHC class I
expression was directly caused by the absence of these tions were performed with a mutant form of CIITA that
does not transactivate MHC class I and II (CIITAm; seeRFX subunits, we transfected SV40-transformed fibro-
blast cell lines derived from BLS patients SSI and OSE Experimental Procedures). This mutant CIITA did not
affect the RFX5-induced transactivation of b2m (data(group C) and ABI (group D) with RFX5 or RFXAP. As
shown in Figure 1A, the level of constitutive MHC class not shown). With respect to MHC class II, RFX5 plus
CIITA markedly induced MHC class II transactivation,I cell surface expression was increased on the RFX5
transfected cells of SSI and OSE (SSI-RFX5 and OSE- whereas CIITA alone could only partially induce MHC
class II. It should also be noted that RFX5 alone did notRFX5) and RFXAP transfected cells of ABI (ABI-RFXAP)
(Figure 1A). induce MHC class II transactivation, as it requires the
(IFNg-induced) expression of CIITA.Northern blot analysis demonstrated that the reduced
level of MHC class I cell surface expression in the BLS Transient cotransfections of the MHC class I promoter
construct with RFXAP in the RFXAP-deficient cell linecell lines correlated with a reduced MHC class I (heavy
chain) as well as b2m transcription (Figure 1B). In the ABI (group D) also resulted in an enhanced MHC class
I transactivation (Figure 2). This suggests that RFXAP,RFX5 transfectants SSI-RFX5 and OSE-RFX5 and the
RFXAP transfectant ABI-RFXAP, the amount of MHC like RFX5, contributes to the constitutive transactivation
of MHC class I. Transfection of RFXAP in combinationclass I as well as b2m transcripts was restored (Figure
1B). The level of MHC class I and b2m transcripts was with CIITA resulted in a further increase of MHC class
I transactivation (Figure 2). In ABI, cotransfection of theinduced by IFNg treatment in all three BLS cell lines but,
in general, did not reach the same levels of that of the b2m reporter construct with RFXAP gave rise to a
marked transactivation (Figure 2). CIITA, when cotrans-transfectants after IFNg induction (Figure 1B). The weak
induction of MHC class II expression by IFNg in ABI fected with RFXAP, further induced transcriptional activ-
ity of b2m (Figure 2). Mutant CIITA did not affect thefibroblasts (Figures 1A and 1B) is most probably caused
by the low levels of IFNg-induced CIITA specific for this RFXAP-induced transactivation of b2m (data not shown).
Similar to the effects in RFX5-deficient cells, CIITA alonecell line (Peijnenburg et al., 1997). These data strongly
suggest that the reduced levels of MHC class I (heavy was unable to give rise to any MHC class I or b2m trans-
activation in this RFXAP-deficient cell line. This is inchain) and b2m are the result of defects in the RFX
complex and that RFX subunits control constitutive contrast to MHC class II transactivation, which was
Immunity
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Figure 2. The RFX Subunits RFX5 and RFXAP Regulate the Constitutive and CIITA-Mediated Transactivation of MHC Class I and b2m
Transactivation
Transient cotransfection assay of MHC class I, b2m, and MHC class II promoter-driven reporter constructs (2 mg/well) with RFX5, RFXAP
(each 1 mg/well), and CIITA (0.1 mg/well) in SSI, OSE (group C), and ABI (group D) fibroblasts and control fibroblasts (WSI). The firefly luciferase
activity values were normalized with the Renilla luciferase activity and are expressed as mean 6 SD of n 5 4.
moderately induced by CIITA alone (Figure 2). In the However, compared with MHC class I and class II, the
wild-type fibroblast cell line WSI, CIITA was sufficient magnitude of the CIITA-mediated induction was weaker
to induce MHC class I, b2m, and MHC class II transacti- for b2m (Table 1).
vation, albeit to various extents (Figure 2). The constitu- Together, these transient transfection data (Figure 2)
tive and CIITA-mediated transactivation of MHC class and the Northern blot analysis data (Figure 1B) argue for
I, b2m, or MHC class II was not enhanced by RFX5 and an important role for the RFX complex in the constitutive
RFXAP (Figure 2), indicating that the levels of RFX5 or transactivation of MHC class I and b2m. Furthermore,
RFXAP are not limiting in control fibroblasts. absence of the RFX components RFX5 or RFXAP abro-
In order to confirm a role of CIITA in b2m transcription, gates the CIITA-mediated transactivation of MHC class
we performed additional transient transfections in the I and b2m.
teratocarcinoma cell line Tera-2. Cotransfection experi-
ments of b2m, MHC class I, and class II reporter con-
structs with different concentrations of CIITA demon- The MHC Class II S-X-Y Regulatory Module Is a
strated that CIITA can induce all three genes (Table 1). Conserved Region in the Proximal Promoter
of MHC Class I and b2m Genes
The finding that the RFX complex regulates MHC class
Table 1. CIITA-Induced Transactivation of b2m Is Weaker Than I and b2m transactivation indicates the existence of RFX
That of MHC Class I or II target sequences in the promoters of MHC class I and
b2m genes. Sequence analysis of the proximal promoterFold Induction
region of MHC class I and b2m genes revealed thatCIITA CIITA CIITAm
sequences which are homologous to the X1X2 box in25 ng/well 500 ng/well 500 ng/well
MHC class II genes can be found (Figure 3). Furthermore,
b2m 7.0 6 0.6 22.0 6 3.1 1.1 6 0.3 in MHC class II the X1X2 box is part of the conserved
Class I 13.7 6 3.8 70.3 6 18.7 1.0 6 0.1
transcriptional regulatory region S-X-Y, and the otherClass II 127.5 6 17.0 271.7 6 31.6 1.1 6 0.2
boxes of this regulatory module were also found to exist
Transient cotransfection assay of b2m, MHC class I, and class II in the proximal promoter region of MHC class I and b2mpromoter-driven reporter constructs with wild-type CIITA (25 or 500
genes. Comparison of the promoter structure of MHCng/well) or mutated CIITA (CIITAm; 500 ng/well) in Tera-2 cells. Fold
class I genes and b2m of different species revealed thatinduction was calculated as the mean luciferase activity of cells
cotransfected with CIITA divided by that of cells cotransfected with this putative S-X-Y regulatory module and the spacing
empty vector. The firefly luciferase activity values were normalized between the individual boxes is highly conserved in sev-
with the Renilla luciferase activity and calculated as mean 6 SD of eral species such as zebrafish, chicken, mouse, gorilla,
n 5 4.
and human (Figure 3).
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vectors of RFX5 and RFXAP in the RFX5- and RFXAP-
deficient fibroblasts. As shown in Figure 4B, mutations
in the X1 box completely blocked the induced MHC
class I and b2m transactivation after complementation
with the defective RFX subunit in these BLS cell lines
(Figure 4B). This demonstrates that the X1 box mediates
the RFX5- and RFXAP-controlled constitutive transacti-
vation of MHC class I and b2m.
The S-X-Y Regulatory Module Is Important
in Constitutive and CIITA-Induced MHC
Class I and b2m Transactivation
Next, the role of all regulatory elements of the S-X-Y
module of MHC class I and b2m was investigated by
transient transfection of HLA-B7 and b2m promoter con-
structs mutated for each individual box (Figure 4A). Mu-
tation of the X1 box resulted in a marked reduction in
the constitutive transactivation of MHC class I and b2m
in wild-type fibroblasts (Figure 4C). Mutations in the
other boxes of the S-X-Y module also resulted in a re-
duction in the constitutive transactivation of MHC class
I and b2m, albeit to various extents (Figure 4C). Further-
more, mutations in the X1, X2, or Y box also completely
blocked (mX1, mX2) or strongly reduced (mY) the CIITA-
induced transactivation of MHC class I and b2m (Figure
4D). Interestingly, mutation of the S box had no marked
effect on the CIITA-induced MHC class I and b2m pro-
moter activity (Figure 4D).
Protein Binding to the X1X2 Box in MHC
Class I and b2m Genes
Finally, the binding of RFX was investigated in electro-
phoretic mobility gel shift assays (EMSAs) using probes
encompassing the X1X2 boxes and flanking sequences
Figure 3. The X Box Is Part of a Conserved S-X-Y Module in the of the MHC class II, class I, and b2m promoters. Several
Proximal Promoter Region of MHC Class I and b2m Genes protein±DNA complexes were formed with the X1X2
Schematic representation of the S-X-Y module and sequence align- probes of MHC class II, class I, and b2m (Figure 5; data
ment of the S, X1X2, and Y boxes of MHC class II, class I, and b2m not shown). Using specific antibodies, these complexes
of human, gorilla, mouse, chicken, and zebrafish. Sequences of
formed with the X1X2 probe of MHC class I and II wereMHC class II accessory genes, the human invariant chain, and HLA-
shown to contain RFX5, X2BP, and ATF/CREB (FigureDM are also depicted. Sequence homology is shown as relative to
5). The complexes formed to the X1X2 probe of b2mthe consensus sequence, in which Y is C/T, R is A/G, M is A/C, K
is G/T, S is G/C, and W is A/T. Numbers above the consensus could be supershifted, albeit weakly, with the ATF/CREB
sequence indicate the positioning relative to the transcription start Ab, whereas binding of RFX5 could not be revealed by
site of the HLA-DRA, HLA-A2, and human b2m genes. The numbers supershift analysis (data not shown). Further analysis
in between the S, X1X2, and Y box sequences indicate the spacing using a range of antisera directed against proteins of the
in number of nucleotides between the boxes. DNA sequences were
ATF/CREB and Fos/Jun families of transcription factorsobtained from the EMBL database. The accession numbers are
revealed the presence of ATF-1, CREB-1, CREM-1, andDRA, HLA-DR (S82636); DRB, HLA-DRB (S57467); DQA, HLA-DQA
Fra-1 in the complexes binding to the X1X2 probe of(M83902); DQB, HLA-DQB (X55425); gorilla DRA (X59619); mouse
I-Aa (M24602); mouse I-Ea (M17389); chicken B class II (L32814); MHC class I and II (data not shown). In addition, su-
zebrafish class II (U08870); HLA-DMA (X76775); HLA-DMB (X76776); pershifts with Abs against c-Jun and c-Fos were de-
Ii, invariant chain (M13555); HLA-A*0201 (L36528); HLA-B*0702 tected, but these were very weak in comparison to su-
(S68087); HLA-Cw5 (M58630); gorilla A class I (L32850); mouse H-2kk pershifts obtained with Abs directed against ATF/CREB
(X61175); chicken class I (M31012); human b2m (M17986); mouse proteins (data not shown). These analyses strongly sug-
b2m (M12485); chicken b2m (Z48922); and zebrafish b2m (L05384).
gest that RFX and X2BP proteins interact with the X1X2
region of the MHC class I promoter and that the proteins
of the X2BP complex may be related or identical to ATF/
The X1 Box Mediates the MHC Class I and b2m CREB proteins.
Transactivation by the RFX Complex
In MHC class II transactivation, the RFX complex is Discussion
shown to bind and exert its activity through the X1 box.
To determine whether the RFX complex also acts through RFX Controls the Constitutive Expression
the X1 box of the MHC class I and b2m promoter, wild- of MHC Class I and b2m
type and X1 box mutant promoter constructs of HLA-B7 In this study, we demonstrate that the aberrant MHC
class I expression in type III BLS cells is a direct resultand b2m (Figure 4A) were cotransfected with expression
Immunity
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Figure 4. The RFX Subunits RFX5 and RFXAP Regulate the Constitutive Transactivation of MHC Class I and b2m Genes through the X1 Box
(A) Nucleotide sequence of the S-X-Y region within the promoter fragments of MHC class I and b2m indicating the mutations in the S, X1, X2,
and Y box.
(B) Transient cotransfection assay of MHC class I and b2m promoter-driven reporter constructs (wt) or their X1 box mutated counterparts
(mX1) with RFX5 and RFXAP in SSI, OSE (group C), and ABI (group D) fibroblasts, respectively. The firefly luciferase activity values were
normalized with the Renilla luciferase activity and are expressed as mean 6 SD of n 5 4.
(C) Transient cotransfection assay of MHC class I and b2m promoter-driven reporter constructs (wt) or their S, X1, X2, or Y box mutated
counterparts (mS, mX1, mX2, or mY, respectively) in control fibroblasts (WSI). The firefly luciferase activity values were normalized with the
Renilla luciferase activity and are expressed as mean 6 SD of n 5 4 relative to wild-type promoter activity (100%).
(D) Transient cotransfection assay of MHC class I and b2m promoter-driven reporter constructs (wt) or their S, X1, X2, or Y box mutated
counterparts (mS, mX1, mX2, or mY, respectively) with CIITA (500 ng/well) in control fibroblasts (WSI). The firefly luciferase activity values
were normalized with the Renilla luciferase activity and are expressed as mean 6 SD of n 5 4.
of the lack of subunits of the RFX complex. The reduced can enhance constitutive MHC class I and b2m transacti-
vation in RFX5- and RFXAP-deficient BLS cell lines re-MHC class I cell surface expression could be restored
by stable transfection of RFX5 and RFXAP in type III veals a new, CIITA-independent function for RFX in the
constitutive expression of MHC class I and b2m genes.BLS fibroblasts of groups C and D, respectively. Further-
more, the reduced levels of MHC class I (heavy chain) However, the RFX complex itself is not known to pos-
sess any transactivation properties. It can therefore beand b2m transcripts indicated that the expression of
these genes was regulated at the transcriptional level. envisaged that RFX fulfills an ancillary function for other
transcription factors that drive constitutive expressionIt was subsequently shown that the RFX subunits RFX5
and RFXAP could directly induce MHC class I and b2m of MHC class I and b2m genes. This would imply that
upstream regulatory elements, which control constitu-transactivation in RFX5 and RFXAP-deficient fibroblasts
and acted through the X1 box. For MHC class II gene tive MHC class I and b2m transactivation (kB and ISRE/
GAS-like sites), are dependent on the RFX complex fortransactivation, the RFX complex acts merely as a medi-
ator of CIITA-driven transactivation (this study; Mach et their function. In this regard, it is of interest to note that
the expression of MHC class I and b2m genes could beal., 1996; Boss, 1997), and MHC class II could not be
transactivated by RFX5 or RFXAP alone in these fibro- induced by IFNg in the RFX5- or RFXAP-deficient cell
lines, albeit that the amount of transcript did not reachblast cell lines. Therefore, the finding that RFX subunits
RFX Regulates MHC Class I and b2m Gene Expression
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Figure 5. Binding of RFX, X2BP, and ATF/CREB Transcription Factors to the X1X2 Box of MHC Class I and II
EMSA and supershift analysis of nuclear extracts from B lymphoblastoid cells (CCRF-SB) incubated with the X1X2 probes of MHC class I
and II. Supershift analysis of the complexes binding to the X1X2 probes of MHC class I and II, employing Abs directed against the N-terminal
or C-terminal domains of RFX5 (RFX5-n and RFX5-c) and against X2BP and ATF/CREB (sc-270; Santa Cruz). The supershifted complexes
are indicated by an asterisk.
the same level as that of the RFX5 or RFXAP transfec- class II. This may explain why this effect was not ob-
served in the past (Gobin et al., 1997; Martin et al., 1997).tants after IFNg induction. This could be due to the
strongly reduced basal levels of MHC class I and b2m The TAP and LMP genes also play an important role
in MHC class I molecule peptide loading and assemblytranscript, but we cannot exclude at this moment
whether the IFNg induction route via the GAS/ISRE ele- (Germain, 1994). However, the level of expression of
these genes was in general not reduced in type III BLSments is compromised by a defective RFX complex.
Furthermore, since IFNg also induces CIITA, the relative patients (Peijnenburg et al., 1995; A. P. et al., unpub-
lished data) and transient cotransfection experimentslow levels of MHC class I and b2m transcripts in the
RFX5- and RFXAP-deficient cell lines after IFNg induc- have revealed that neither RFX5, RFXAP, nor CIITA have
a significant effect on TAP1 and LMP2 transactivationtion may also be the consequence of the inability of
CIITA to transactivate these genes through a defective in these cell lines (S. J. P. G. et al., unpublished data).
RFX complex (see below).
A Functional S-X-Y Module in MHC Class I
and b2m GenesThe RFX Complex Is Crucial for the CIITA-Mediated
Route of MHC Class I and b2m Transactivation The overall promoter structure and expression regula-
tion of MHC class I genes have been considered differ-For CIITA-mediated transactivation of MHC class II, the
RFX complex fulfills a crucial role (Mach et al., 1996; ent in many aspects from those of MHC class II genes.
However, the presence of conserved S, X1, X2, and YBoss, 1997). However, (over)expression of CIITA in RFX-
deficient BLS cell lines still results in a moderate trans- elements in the proximal promoter region of MHC class
II, class I, and b2m genes indicates a common use ofactivation of HLA-DRA (this study; Peijnenburg et al.,
1997). In this study, it is shown that MHC class I trans- this regulatory module.
Mutation analysis of the individual S, X1, X2, and Yactivation by CIITA is completely blocked when one of
the RFX subunits is absent. This strongly suggests that, boxes has demonstrated that all boxes of the S-X-Y
module in the MHC class I and b2m promoters contributein addition to ATF/CREB proteins (Gobin et al., 1997;
Martin et al., 1997), the RFX complex is crucial for the to constitutive transactivation. This is in agreement with
previous reports on the importance of the X2 box/siteCIITA-mediated route of MHC class I transactivation. In
addition, CIITA also regulates b2m transactivation and a (Dey et al., 1992; Gobin et al., 1997) and Y box (the
inverted CCAAT box; Schoneich et al., 1997) in constitu-is also dependent on the RFX complex. However, the
level of induction is weaker than for MHC class I and tive MHC class I transactivation. Furthermore, the X1,
Immunity
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X2, and Y boxes were all shown to be important for as an enhanceosome (Carey, 1998) as has been de-
scribed for the IFNb gene promoter (Kim and Maniatis,CIITA-induced transactivation. Interestingly, mutations
in the S box did not seem to affect CIITA-mediated 1998).
It should be noted that the group of upstream regula-transactivation of MHC class I and b2m. These observa-
tions are in line with findings in MHC class II that most, tory elements (kB and ISRE/GAS-like sites) that deter-
mine constitutive and cytokine induced expression ofif not all, boxes of the S-X-Y module are important in
CIITA-mediated transactivation (Riley et al., 1995; Zhou MHC class I and b2m are in general absent in MHC class
II genes (Salter-Cid and Flajnik, 1995). These ISRE/GASand Glimcher, 1995). Together, they strongly suggest
that the X1 box of the MHC class I and b2m promoter and kB elements are juxtaposed, act in synergy (John-
son and Pober, 1994; Drew et al., 1995), and may there-is part of an S-X-Y module of which the individual boxes
act in concert, as has been described for MHC class II fore be viewed as a second regulatory module in the
promoters of MHC class I and b2m genes. It is tempting(Louis-Plence et al., 1997; Fontes et al., 1997a).
to speculate that proteins binding this upstream regula-
tory module interact with the protein complex bindingIs the S-X-Y Module the Basis for
Enhanceosome Formation? the S-X-Y module, and it could also be envisaged that
for MHC class I and b2m, stabilization of the complexIn MHC class II, the X1 box is the target site for the RFX
complex. The complexes binding to the X1X2 element could be accomplished by transcription factors binding
this upstream regulatory module.of MHC class I contained at least the RFX subunit RFX5.
Similarly, the X1X2 element (containing site a) in MHC
class I was bound by X2BP, a complex consisting princi- Is the S-X-Y Module an Ancestral Regulatory
pally of members of the ATF/CREB family of transcrip- Region of MHC Genes?
tion factors (this study; Boss, 1997, Gobin et al., 1997; The strong conservation of the S-X-Y module in MHC
J. M. Boss, personal communication). In contrast, the among several species (Kroemer et al., 1990; Gaur et
X1X2 element of b2m displayed a reduced affinity for al., 1992; Ono et al., 1993; Vallejo and Pease, 1995;
X2BP/ATF/CREB and no detected binding of RFX5 in Riegert et al., 1996), suggests that this regulatory mod-
our experimental setup. The Y box (containing the in- ule may have been present in an ancestral MHC gene. It
verted CCAAT box) in MHC class II is also found in MHC can be hypothesized that the promoter of this ancestral
class I and b2m genes (this study; GuÈ ssow et al., 1987; MHC gene also contained the upstream regulatory mod-
Schoneich et al., 1997). Finally, a sequence homologous ule. MHC class I genes could have evolved from this
to the S box of MHC class II is found in MHC class I ancestral MHC gene with little change in overall pro-
and b2m genes (this study; Riegert et al., 1996). Thus, moter structure. MHC class II genes would then have
all regulatory elements of the S-X-Y module in MHC evolved in a divergent evolutionary line, maintaining only
class II have their counterparts in MHC class I and b2m the S-X-Y module. This fits the hypothesis that a gener-
genes. The RFX-X2BP-NFY complex binding to the ally expressed MHC molecule (MHC class I) preceded
S-X-Y region of the MHC class II gene promoter is highly an MHC molecule with restricted expression patterns
stable (Louis-Plence et al., 1997). Interestingly, this com- (MHC class II), due to the fact that MHC class II has the
plex can be formed relatively independent of the ability more specialized functions (Flajnik et al., 1991; Kaufman
of the individual proteins to bind the different boxes. It et al., 1994). Furthermore, it could have been of signifi-
appears that in the formation of these complexes, the cance that during the course of evolution, MHC class
anchoring can be at different contact points of the S-X-Y II molecules would have lost the upstream regulatory
module and does not depend on the various proteins module responsible for constitutive expression, thus
making contact with all of the individual boxes (Louis- making them fully dependent on the presence of CIITA-
Plence et al., 1997). This could explain the controversial mediated transactivation through the RFX-X2BP-NFY
finding that RFX plays an important role in the constitu- complex. This provides a mechanism which ensures that
tive transactivation of b2m, despite the weak, if any, the constitutive expression of MHC class II molecules,
binding to the X1X2 box. In analogy to MHC class II, the with their more specialized functions in antigen presen-
Y (and S) box and its proteins could be important for tation, is confined only to antigen-presenting cells of
the formation of a stable high-affinity protein complex the immune system, where CIITA is constitutively ex-
(Wright et al., 1994; Jabrane-Ferrat et al., 1996; Fontes pressed. In keeping with their more general functions
et al., 1997a; Moreno et al., 1997). Apart from the conser- of antigen presentation, MHC class I molecules could
vation of the individual regulatory elements, the spacing still have retained their ubiquitous expression. Thus, the
between the elements is also conserved in MHC class S-X-Y module, combined in MHC class I and b2m with
II, class I, and b2m promoters. The spacing in MHC class the upstream regulatory module, may determine the dif-
II promoters is such that the region encompasses two ferential expression patterns of MHC molecules. Conse-
helical turns and it places the particular boxes on the quently, this allows for the fulfillment of specialized tasks
same side of the helix, which is crucial for the formation of MHC class I and MHC class II molecules within their
of a higher order protein±DNA complex containing RFX, general range of functions in the immune response.
X2BP, and NFY (Wright et al., 1994; Fontes et al., 1997a).
Interactions of CIITA with RFX5 and TAFII32 (Fontes et
Experimental Proceduresal., 1997b; Mahanta et al., 1997; Scholl et al., 1997) sug-
gest that CIITA forms a link between the RFX-X2BP- Cell Culture
NFY complex and the basal transcription initiation com- Cell lines used in this study were the B lymphoblastoid cell line
CCRF-SB (American Type Culture Collection, Rockville, MD), theplex. As such, this multiprotein complex could function
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teratocarcinoma cell line Tera-2 (ATCC), and the SV40 transformed ng of pREP4-CIITA (as indicated). Luciferase activity was deter-
mined using the dual-luciferase reporter assay system (Promega)fibroblast lines SSI, OSE, ABI, WSI, and DermT. SSI and OSE primary
fibroblasts were grown out of skin biopsies from BLS patients that and a luminometer (Tropix, Bedford, MA).
have been characterized as being defective in RFX5 (group C; A. P.
et al., unpublished data). Cell material of patients SSI and OSE was Generation of Stable Cell Lines Transfected
obtained through Dr. J. M. J. J. Vossen and Dr. OÈ . Sanal and of with RFX5, RFXAP, and CIITA
patient ABI through Dr. E. Dupont. ABI fibroblasts were character- Adherent cell lines were transfected according to the calcium phos-
ized previously (Peijnenburg et al., 1995) and shown to be mutated phate coprecipitation method, as described above, with pREP4-
in RFXAP (Villard et al., 1997), which is the gene defective in group RFX5, pREP4-RFXAP, or empty vector (pREP4) and grown on selec-
D BLS patients (Durand et al., 1997). WSI and DermT fibroblasts tion medium. After selection on 50 mg/ml hygromycin B (Boehringer
were derived from healthy controls. All cells were grown in Iscove's Mannheim, Mannheim, Germany) for an average of 2 weeks, hygro-
modified DMEM supplemented with 10% (v/v) heat-inactivated fetal mycin-resistant colonies were pooled.
calf serum (GIBCO, Paisley, Scotland), penicillin (100 IU/ml), and
streptomycin (100 mg/ml). For induction experiments, recombinant Flow Cytometric Analysis
human IFNg (Boehringer Ingelheim, Ingelheim, Germany) was used Subconfluent cultures of the RFX5, RFXAP, or mock transfected
at a concentration of 250 U/ml. cells (untreated or treated with IFNg 250 U/ml) were stained by
indirect immunofluorescence with an anti-HLA-DR MAb or the anti-
MHC class I MAb W6/32 as first Ab and an FITC-conjugated anti-Antibodies
mouse IgG as second Ab (Becton-Dickinson). The analysis wasThe antibodies (Abs) used were directed against ATF/CREB (sc-270),
performed on a FACScan flow cytometer (Becton-Dickinson) usingCREB1 (sc-271), CREB2 (sc-200), CREM1 (sc-440), ATF1 (sc-243),
FACScan and LYSIS software. Pools of the cell lines transfectedATF2 (sc-187), ATF3 (sc-188), Jun (sc-44), c-Jun (sc-45), JunB (sc-
with pREP4 (mock transfected cells) served as a negative control.46), anti-JunD Ab (sc-74), Fos (sc-253), c-Fos (sc-52), FosB (sc-
48), Fra1 (sc-605), and Fra2 (sc-171; all Abs are from Santa Cruz
Electrophoretic Mobility Gel Shift AssayBiotechnology, Santa Cruz, CA). The anti RFX5 Abs were purchased
Nuclear extracts were prepared as described before (Gobin et al.,from Rockland (Gilbertsville, PA). RFX5-n Ab (200±401±193) is raised
1997). The total amount of protein was determined using the BCAagainst the N-terminal region (amino acids 1±260) and RFX5-c Ab
Protein Assay Reagent kit (Pierce, Rockford, IL) according to the(200±401±191) is raised against the C-terminal region (Moreno et
manufacturer's instructions.al., 1997). The antiserum against CREB-1 cross-reacts with the 46
For an electrophoretic mobility gel shift assay (EMSA), nuclearkDa subunit of X2BP and is used as X2BP antiserum (a kind gift of
extracts (5 mg protein) were incubated in DNA±protein binding bufferDr. J. Boss; Moreno et al., 1995).
(10 mM HEPES [pH 7.9], 60 mM KCl, 10% v/v glycerol, 1 mM DTT,
1 mM EDTA, 3 mM MgCl2, and 10 mM NaPi), with 200 ng poly(dI´dC),
Plasmids 200 ng sonicated single-stranded herring sperm DNA, and 1 ng [32P]-
Luciferase reporter plasmids used were generated by cloning geno- radiolabeled probe for 30 min at 48C. The samples were run on a
mic promoter fragments into pGL3-Basic (Promega, Madison, WI). 6% nondenaturing polyacrylamide gel in 0.253 TBE buffer at 200
These constructs contain, respectively, a 294 bp XbaI±SacI HLA- V for 2 hr. The gels were fixed with a 10% methanol, 10% acetic
DRA promoter fragment (pGL3-DRA), a 269 bp AspI±AhaII HLA-B7 acid solution, dried onto Whatmann 3M paper, and exposed to an
promoter fragment (pGL3-B250), or a 302 bp b2m promoter fragment X-ray film. The ds-oligonucleotide encompassing the X1X2 box of
that was generated by PCR amplification (pGL3-b2m). The genomic HLA-DRA (class II-X1X2: ctagaCTTCCCCTAGCAACAGATGCGTCA
human b2m plasmid was used as a template (a kind gift of Dr. H. L. TCTCAt), HLA-B7 (class I-X1X2: ctagaCTTCTTCCAGGATACTCG
Ploegh; GuÈ ssow et al., 1987). The S, X1, X2, and Y box mutant TGACGCGTCCCCt), and b2m (b2m-X1X2: ctagaCGCTGGCTTGG
promoter constructs of HLA-B7 and b2m were generated by overlap AGACAGGTGACGGTCCTGCGt) were used as probes for EMSAs.
extension PCR (Gobin et al., 1997). These mutant promoter con- For the supershift assays, 1 mg of each antiserum was added to
structs are identical to the wild-type constructs (pGL-B250 and the nuclear extract and probe mixture after 30 min and incubated
pGL3-b2m) except for a 4±5 bp mutation in the core sequence of for an additional hour or overnight at 48C.
the individual boxes (as depicted in Figure 4A). All plasmids were
verified by sequence analysis (T7-polymerase sequence kit; Amer- Northern Blot
sham, Buckinghamshire, United Kingdom). Total RNA was isolated from subconfluent cultures by the RNAzol
The plasmid pREP4 is an episomal expression vector (Invitrogen, extraction method (Cinna/Biotecx Laboratories, Houston, TX). The
San Diego, CA) in which the expression of a cDNA to be cloned is cells were either untreated or treated with IFNg (500 U/ml) for 48 hr
driven by promoter sequences from the rous sarcoma virus long prior to harvesting. RNA samples (20 mg per lane) were run on a
terminal repeat. The expression vector pREP4-RFX5 was con- 1.2% agarose gel containing 2.2 M formaldehyde, transferred to a
structed by insertion of a 3.4 kb HindIII±SalI fragment of pEBO- Hybond-N membrane, and hybridized with 32P-labeled probes (ran-
pLPP/RFX5 (kindly provided by Drs. B. Mach and W. Reith; Steimle dom priming; DuPont-NEN, Boston, MA) as described previously
et al., 1995) into pREP4. Construct pREP4-RFXAP contains a 2.1 (Gobin et al., 1997).
kb full-length RFXAP cDNA fragment and was obtained by hybridiza-
tion screening of a B cell library in pREP4 (a kind gift of Dr M. Acknowledgments
Buchwald). The expression vector pREP4-CIITA is described pre-
viously (Gobin et al., 1997). The expression vector pREP4-CIITAm The authors thank Drs. C. S. Bigland, R. Bontrop, F. Koning, and B.
was generated by cloning of cDNA of the mutant CIITA form of the Roep for critically reading the manuscript and Dr. J. M. Boss for
group A BLS cell line ATU (A. P. et al., unpublished data). communicating results prior to publication. The authors also thank
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for their gift of the RFX5 cDNA. This work was supported by theTransient Transfection
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search (grant 96±248 MS), the Macropa Foundation, and the Nether-method (Chen and Okayama, 1987). In each of 4 wells of a 6-well
lands Organization for Research (NWO grant 901±09±243).plate, 0.25 3 106 fibroblast cells were transfected with a DNA mix
containing 2 mg firefly luciferase pGL3 reporter plasmid (pGL3-B250,
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pRL-TK control plasmid (Promega), and 1 mg of pREP4-RFX5, 1 mg
pREP4-RFXAP, and/or 100 or 500 ng of pREP4-CIITA (as indicated). References
Cells were harvested 3 days after transfection. Tera-2 cells were
transfected with 0.5 mg pGL3 reporter plasmid and 0.05 mg of Renilla Boehm, U., Klamp, T., Groot, M., and Howard, J.C. (1997). Cellular
responses to interferon-g. Annu. Rev. Immunol. 15, 749±795.luciferase pRL-SV40 control plasmid (Promega) and 25, 100, or 500
Immunity
540
Boss, J.M. (1997). Regulation of transcription of MHC class II genes. Le Bouteiller, P. (1994). HLA class I chromosomal region, genes,
Curr. Opin. Immunol. 9, 107±113. and products: facts and questions. Crit. Rev. Immunol. 14, 89±129.
Carey, M. (1998). The enhanceosome and transcriptional synergy. Lonergan, M., Dey, A., Becker, K.G., Drew, P.D., and Ozato, K. (1993).
Cell 92, 5±8. A regulatory element in the b2-microglobulin promoter identified by
in vivo footprinting. Mol. Cell. Biol. 13, 6629±6639.Chen, C., and Okayama, H. (1987). High-efficiency transformation
of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7, 2745±2752. Louis-Plence, P.L., Moreno, C.S., and Boss, J.M. (1997). Formation
of a regulatory factor X/X2 Box-binding protein nuclear factor-YDey, A., Thornton, A.M., Lonergan, M., Weissman, S.M., Chamber-
multiprotein complex on the conserved regulatory regions on HLAlain, J.W., and Ozato, K. (1992). Occupancy of upstream regulatory
class II genes. J. Immunol. 159, 3899±3909.sites in vivo coincides with major histocompatibility complex class
I gene expression in mouse tissues. Mol. Cell. Biol. 12, 3590±3599. Mach, B., Steimle, V., Martinez-Soria, E., and Reith, W. (1996). Regu-
lation of MHC class II genes: lessons from a disease. Annu. Rev.Drew, P.D., Franzoso, G., Becker, K.G., Bours, V., Carlson, L.M.,
Siebenlist, U., and Ozato, K. (1995). NFkB and interferon regulatory Immunol. 14, 301±331.
factor 1 physically interact and synergistically induce major histo- Mahanta, S.K., Scholl, T., Yang, F.C., and Strominger, J.L. (1997).
compatibility class I gene expression. J. Interferon Cytokine Res. Transactivation by CIITA, the type II bare lymphocyte syndrome-
15, 1037±1045. associated factor, requires participation of multiple regions of the
Durand, B., Sperisen, P., Emery, P., Barra, E., Zufferey, M., Mach, TATA box binding protein. Proc. Natl. Acad. Sci. USA 94, 6324±6329.
B., and Reith, W. (1997). RFXAP, a novel subunit of the RFX DNA Mansky, P., Brown, W.M., Park, J.-H., Choi, J.W., and Yang, S.Y.
binding complex is mutated in class II deficiency. EMBO J. 16, (1994). The second kB element, kB2, of the HLA-A class I regulatory
1045±1055. complex is an essential part of the promoter. J. Immunol. 153, 5082±
Flajnik, M.F., Canel, C., Kramer, J., and Kasahara, M. (1991). Which 5090.
came first, MHC class I or MHC class II? Immunogenetics 33, Martin, B.K., Chin, K.-C., Olsen, J.C., Skinner, C.A., Dey, A., Ozato,
295±300. K., and Ting, J.Y.-P. (1997). Induction of MHC class I expression by
Fontes, J.D., Jabrane-Ferrat, N., and Peterlin, B.M. (1997a). Assem- the MHC class II transactivator CIITA. Immunity 6, 591±600.
bly of functional regulatory complexes on MHC class II promoters Moreno, C.S., Emery, P., West, J.E., Durand, B., Reith, W., Mach,
in vivo. J. Mol. Biol. 270, 336±345. B., and Boss, J.M. (1995). Purified X2 binding protein (X2BP) cooper-
Fontes, J.D., Jiang, B., and Peterlin, B.M. (1997b). The class II trans- atively binds the class II MHC X box region in the presence of purified
activator CIITA interacts with the TBP-associated factor TAFII32. RFX, the X box factor deficient in the bare lymphocyte syndrome.
Nucleic Acid Res. 25, 2522±2528. J. Immunol. 155, 4313±4321.
Gaur, L.K., Heise, E.R., and Ting, J.P. (1992). Conservation of the Moreno, C.S., Rogers, E.M., Brown, J.A., and Boss, J.M. (1997).
promoter region of DRA-like genes from nonhuman primates. Immu- Regulatory factor X, a bare lymphocyte syndrome transcription fac-
nogenetics 35, 136±139. tor, is a multimeric phosphoprotein complex. J. Immunol. 158, 5841±
Germain, R.N. (1994). MHC-dependent antigen processing and pep- 5848.
tide presentation: providing ligands for T lymphocyte activation. Cell Ono, H., Figueroa, F., O'Huigin, C., and Klein, K.A. (1993). Cloning
76, 287±299. of the beta 2-microglobulin in the zebrafish. Immunogenetics 38,
Girdlestone, J., Isamat, M., Gewert, D., and Milstein, C. (1993). Tran- 1±10.
scriptional regulation of HLA-A and -B: differential binding of mem- Peijnenburg, A., Godthelp, B., Van Boxel-Dezaire, A., and Van den
bers of the Rel and IRF families of transcription factors. Proc. Natl. Elsen, P.J. (1995). Definition of a novel complementation group in
Acad. Sci. USA 90, 11568±11572.
MHC class II deficiency. Immunogenetics 41, 287±294.
Gobin, S.J.P., Peijnenburg, A., Keijsers, V., and Van den Elsen, P.J.
Peijnenburg, A., Gobin, S.J., Van Eggermond, M.C., Godthelp, B.C.,
(1997). Site a is crucial for two routes of IFNg-induced MHC class
Van Graafeiland, N., and Van den Elsen, P.J. (1997). Introduction ofI transactivation: the ISRE-mediated route and a novel pathway
exogenous class II trans-activator in MHC class II-deficient ABIinvolving CIITA. Immunity 6, 601±611.
fibroblasts results in incomplete rescue of MHC class II antigen
GuÈ ssow, D., Rein, R., Ginjaar, I., Hochstenbach, F., Seemann, G., expression. J. Immunol. 159, 2720±2727.
Kottman, A., and Ploegh, H.L. (1987). The human b2-microglobulin
Reith, W., Siegrist, C.-A., Durand, B., Barras, E., and Mach, B. (1994).gene. Primary structure and definition of the transcriptional unit. J.
Function of major histocompatibility complex II promoters requiresImmunol. 139, 3132±3138.
cooperative binding between factors RFX and NF-Y. Proc. Natl.
IsraeÈ l, A., Kimura, A., Kieran, M., Yano, O., Kanellopoulos, J., Le Acad. Sci. USA 91, 554±558.
Bail, O., and Kourilsky, P. (1987). A common positive trans-acting
Riegert, P., Andersen, R., Bumstead, N., DoÈ hring, C., Dominguez-factor binds to enhancer sequences in the promoter of mouse H-2
Steglich, M., Engberg, J., Salomonsen, J., Schmid, M., Schwager,and b2-microglobulin genes. Proc. Natl. Acad. Sci. USA 84, 2653±
J., Skjùdt, K., and Kaufman, J. (1996). The chicken b2-microblobulin2657.
gene is located on a non-major histocompatibility complex micro-Jabrane-Ferrat, N., Fontes, J.D., Boss, J.M., and Peterlin, B.M.
chromosome: A small, G 1 C-rich gene with X and Y boxes in the(1996). Complex architecture of major histocompatibility complex
promoter. Proc. Natl. Acad. Sci. USA 93, 1243±1248.class II promoters: reiterated motifs and conserved protein-protein
Riley, J.L., Westerheide, S.D., Price, J.A., Brown, J.A., and Boss,interactions. Mol. Cell. Biol. 16, 4683±4690.
J.M. (1995). Activation of class II MHC genes requires both theJohnson, D.R., and Pober, J.S. (1994). HLA class I heavy-chain gene
X box region and the class II transactivator (CIITA). Immunity 2,promoter elements mediating synergy between tumor necrosis fac-
533±543.tor and interferons. Mol. Cell. Biol. 14, 1322±1332.
Sabatier, C., Gimenez, C., Calin-Laurens, V., Rabourdin-Combe, C.,Kaufman, J., Salomonsen, J., and Flajnik, M. (1994). Evolutionary
and Touraine, J.-L. (1996). Type III bare lymphocyte syndrome: lackconservation of MHC class I and class II moleculesÐdifferent yet
of HLA class II gene expression and reduction in HLA class I genethe same. Semin. Immunol. 6, 411±424.
expression. CR Acad. Sci. III 319, 789±798.Kim, T.K., and Maniatis, T. (1998). The mechanism of transcriptional
Salter-Cid, L., and Flajnik, M.F. (1995). Evolution and developmentalsynergy of an in vitro assembled interferon-b enhanceosome. Mol.
regulation of the major histocompatibility complex. Crit. Rev. Immu-Cell 1, 119±129.
nol. 15, 31±75.Kroemer, G., Zoorob, R., and Auffrey, C. (1990). Structure and ex-
Scholl, T., Mahanta, S.K., and Strominger, J.L. (1997). Specific com-pression of a chicken MHC class I gene. Immunogenetics 31,
plex formation between the type II bare lymphocyte syndrome-asso-405±409.
ciated transactivator CIITA and RFX5. Proc. Natl. Acad. Sci. USALambert, M., Van Eggermond, M., Andrien, M., Mascart, F., Vamos,
94, 6330±6334.E., Dupont, E., and Van den Elsen, P.J. (1991). Analysis of the periph-
Schoneich, J., Lee, J.L., Mansky, P., Sheffery, M., and Yang, S.Y.eral T-cell compartment in the MHC class II deficiency syndrome.
Res. Immunol. 142, 789±798. (1997). The pentanucleotide ATTGG, the ªinverted CCAAT,º is an
RFX Regulates MHC Class I and b2m Gene Expression
541
essential element for HLA class I gene transcription. J. Immunol.
158, 4788±4796.
Silacci, P., Mottet, A., Steimle, V., Reith, W., and Mach, B. (1994).
Developmental extinction of major histocompatibility complex class
II gene expression in plasmocytes is mediated by silencing of the
transactivator gene CIITA. J. Exp. Med. 180, 1329±1336.
Steimle, V., Otten, L.A., Zufferey, M., and Mach, B. (1993). Comple-
mentation cloning of an MHC class II transactivator mutated in he-
reditary MHC class II deficiency (or bare lymphocyte syndrome).
Cell 75, 135±146.
Steimle, V., Durand, B., Barras, E., Zufferey, M., Hadam, M.R., Mach,
B., and Reith, W. (1995). A novel DNA-binding regulatory factor
is mutated in primary MHC class II deficiency (bare lymphocyte
syndrome). Genes Dev. 9, 1021±1032.
Ting, J.P.-Y., and Baldwin, A.S. (1993). Regulation of MHC gene
expression. Curr. Opin. Immunol. 5, 8±16.
Touraine, J.-L., Marseglia, G.-L., and Betuel, H. (1985). Thirty interna-
tional cases of bare lymphocyte syndrome: biological significance
of HLA antigens. Exp. Hematol. 13, 86±87.
Vallejo, A.N., and Pease, L.R. (1995). Evolution of class I promoter
sequences: relationship to function and diversity. Immunol. Rev.
143, 249±262.
Villard, J., Lisowska-Grospierre, B., Van den Elsen, P., Fischer, A.,
Reith, W., and Mach, B. (1997). Mutation of RFXAP, a regulator of
MHC class II genes, in primary MHC class II deficiency. N. Engl. J.
Med. 337, 748±753.
Wright, K.L., Vilen, B.J., Itoh-Lindstrom, Y., Moore, T.L., Li, G., Crisci-
tiello, M., Cogswell, P., Clarke, J.B., and Ting, J.P.-Y. (1994). CCAAT
box binding protein NF-Y facilitates in vivo recruitment of upstream
DNA binding transcription factors. EMBO J. 13, 4042±4053.
Zeleznik-Le, N., Azizkhan, J.C., and Ting, J.P.-Y. (1991). Affinity puri-
fied CCAAT-box-binding protein (YEBP) functionally regulates ex-
pression of a human class II major histocompatibility complex gene
and the herpes simplex virus thymidine kinase gene. Proc. Natl.
Acad. Sci. USA 88, 1873±1877.
Zhou, H., and Glimcher, L.H. (1995). Human MHC class II gene
transcription directed by the carboxyl terminus of CIITA, one of
the defective genes in type II MHC combined immune deficiency.
Immunity 2, 545±553.
